|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/33 | (2006.01) |
| A61K 31/33 | (2013.01) | ||
| A61P 9/12 | (2018.01) | ||
| A61K 31/325 | (2013.01) |
| (11) | Number of the document | 3209291 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15787849.7 |
| Date of filing the European patent application | 2015-10-22 | |
| (97) | Date of publication of the European application | 2017-08-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/056824 |
| Date | 2015-10-22 |
| (87) | Number | WO 2016/065103 |
| Date | 2016-04-28 |
| (30) | Number | Date | Country code |
| 201462067916 P | 2014-10-23 | US |
| (72) |
GLICKLICH, Alan , US
|
| (73) |
Arena Pharmaceuticals, Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
| (54) | METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR |
| METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR |